Definium Therapeutics Correlations

DFTX Stock

16.25 0.78 4.58%

The correlation of Definium Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Definium Therapeutics Correlation With Market

Poor diversification

The correlation between Definium Therapeutics and DJI is 0.79 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Definium Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Definium Stock

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Definium Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty.

For more information on how to buy Definium Stock please use our How to Invest in Definium Therapeutics guide.

Moving together with Definium Stock

0.75	NONOF	Novo Nordisk AS	Pair Corr
0.74	NVO	Novo Nordisk AS	Pair Corr
0.7	VRTX	Vertex Pharmaceuticals	Pair Corr
0.64	CSLLY	CSL Earnings Call This Week	Pair Corr
0.84	PPHI	Positive Physicians	Pair Corr
0.9	COCCF	Coast Copper Corp	Pair Corr
0.86	NKWFF	Oceanic Wind Energy	Pair Corr
0.92	TTC	Toro	Pair Corr
0.79	AMP	Ameriprise Financial	Pair Corr
0.71	CLKXF	TWC Enterprises	Pair Corr
0.82	TCBI	Texas Capital Bancshares	Pair Corr
0.94	IFS	Intercorp Financial Earnings Call This Week	Pair Corr
0.83	UNF	Unifirst	Pair Corr
0.8	RKLIF	Rentokil Initial plc	Pair Corr
0.93	RBA	RB Global	Pair Corr
0.77	GS	Goldman Sachs Group	Pair Corr
0.81	ACGYF	Subsea 7 SA	Pair Corr

Moving against Definium Stock

0.85	ALNY	Alnylam Pharmaceuticals Earnings Call This Week	Pair Corr
0.6	LPTV	Loop Media	Pair Corr
0.59	ARGX	argenx NV ADR	Pair Corr
0.52	FHLD	Freedom Holdings	Pair Corr
0.4	DECAU	Denali Capital Acqui	Pair Corr
0.77	FATBB	FAT Brands	Pair Corr

Related Correlations Analysis

	BBDA	SAM	BRCB	ATGN	DRI	TAP-A	HCEI
BBDA		0.0	0.0	0.0	0.0	0.0	1.0	BBDA
SAM	0.0		-0.69	-0.63	0.79	0.48	0.0	SAM
BRCB	0.0	-0.69		0.61	-0.62	-0.53	0.0	BRCB
ATGN	0.0	-0.63	0.61		-0.85	-0.66	0.0	ATGN
DRI	0.0	0.79	-0.62	-0.85		0.7	0.0	DRI
TAP-A	0.0	0.48	-0.53	-0.66	0.7		0.0	TAP-A
HCEI	1.0	0.0	0.0	0.0	0.0	0.0		HCEI
	BBDA	SAM	BRCB	ATGN	DRI	TAP-A	HCEI

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

HCEI	+ 1.0	BBDA
DRI	+ 0.79	SAM
TAP-A	+ 0.7	DRI
ATGN	+ 0.61	BRCB
TAP-A	+ 0.48	SAM
SAM	+ 0.0	BBDA

High negative correlations

DRI	- 0.85	ATGN
BRCB	- 0.69	SAM
TAP-A	- 0.66	ATGN
ATGN	- 0.63	SAM
DRI	- 0.62	BRCB
TAP-A	- 0.53	BRCB

Risk-Adjusted Indicators

There is a big difference between Definium Stock performing well and Definium Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Definium Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
BBDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SAM	1.52	0.22	0.10	1.36	1.70	(1.71)	3.36	(2.66)	7.94
BRCB	2.99	(0.90)	0.00	(0.30)	0.00	0.00	4.19	(6.81)	18.97
ATGN	2.44	(0.50)	0.00	0.70	0.00	0.00	4.65	(5.77)	34.04
DRI	1.36	0.24	0.16	0.30	1.29	(1.62)	3.28	(2.51)	8.67
TAP-A	1.07	0.14	0.03	(0.90)	1.46	(3.67)	4.30	(3.22)	16.43
HCEI	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Definium Therapeutics Corporate Management

Gitanjali Ogawa	VP Relations	Profile
Mark JD	Chief Secretary	Profile
Peter Mack	Senior Operations	Profile
MD MA	Chief Officer	Profile
Stephanie Fagan	Chief Officer	Profile
Beth Calitri	Vice Communications	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC